“We weren’t happy when a billboard went up saying marijuana laws reduce overdose deaths,” said Brendan Saloner of Johns Hopkins Berman Institute of Bioethics & Bloomberg School of Public Health. “That was very hard for us to rein in.”

Quick Read

Some drug users say that as long as the lifesaving drug is around, they don’t worry as much about dying

Quick Read

Federal prosecutors accused the company of illegally marketing its powerful fentanyl painkiller and of defrauding government health care programs

Quick Read

Our Travis Rieder talks about his forthcoming book, ‘In Pain’, and explores the role of prescription opioids in American medicine with folks from the Advanced Academic Programs at Johns Hopkins

Quick Read

“Buprenorphine patients remain disproportionately white and, while whites are more likely to have opioid addiction, the difference in prevalence alone is unlikely to explain this gap,” commented our Brendan Saloner

Quick Read

Our Brendan Saloner on Neonatal Abstinence Syndrome (NAS), a withdrawal condition that is the result of prenatal exposure to opioids, and the impact of community social stress on opioid use and NAS

Quick Read

“When people get signed up for Medicaid, it increases the likelihood that they will seek all types of medical care including more visits to primary care doctors, and even when patients are not explicitly seeking care for opioid addiction, the greater contact with the health system creates more opportunities…” said lead study author Brendan Saloner

Quick Read

For decades, the Sackler family has generously supported museums worldwide. But now some favorite Sackler charities are reconsidering whether they want the money at all, and several have already rejected any future gifts, concluding that some family members’ ties to the opioid crisis outweighed the benefits

Quick Read